“Manufacturers should play an active role during the post-market phase by systematically and actively gathering information from post-market experience with their devices.” -EU MDR
As May 2020 quickly approaches, the EU MDR post-market surveillance (PMS) phase of the total product lifecycle is changing. And we understand that global medical device manufacturers like yours are working to fully understand the impact to your organization, as well as what actions and resources are critical to ensure the safety and efficacy of your products - from product release to retirement.
Device Talks – West will take place in Santa Clara on December 9-10, 2019. Amplexor, together with Regulatory Compliance Associates® Inc. (RCA) will be hosting a roundtable breakfast discussion, also known as a ‘Table Talk’, on 10 December at the Santa Clara Convention Center.